Catalyst Pharmaceuticals, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US14888U1016
USD
23.08
0.46 (2.03%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
146.56
141.42
141.82
128.69
122.71
98.51
110.57
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
146.56
141.42
141.82
128.69
122.71
98.51
110.57
Raw Material Cost
29.96
27.26
30.99
28.62
24.75
21.86
24.87
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
45.95
46.91
44.19
45.88
40.73
46.94
42.04
Other Expenses
0.44
0.39
0.38
0.33
0.30
0.26
0.20
Total Expenditure (Excl Depreciation)
80.27
78.05
78.98
77.79
68.46
71.38
68.88
Operating Profit (PBDIT) excl Other Income
66.3
63.4
62.800000000000004
50.9
54.2
27.1
41.7
Other Income
5.95
5.28
4.62
4.54
3.80
3.11
5.01
Operating Profit (PBDIT)
81.71
78.10
76.99
64.97
67.55
39.73
55.85
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Items
-2.95
2.64
6.72
1.76
-2.26
-1.14
0.00
Gross Profit (PBDT)
116.61
114.17
110.83
100.07
97.96
76.64
85.70
Depreciation
9.46
9.46
9.53
9.52
9.50
9.50
9.14
Profit Before Tax
69.29
71.29
74.18
57.20
55.79
29.09
46.71
Tax
17.18
14.55
18.25
13.32
14.99
5.81
11.86
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
52.11
56.74
55.94
43.88
40.79
23.27
34.84
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
52.11
56.74
55.94
43.88
40.79
23.27
34.84
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
52.11
56.74
55.94
43.88
40.79
23.27
34.84
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
856.03
794.28
727.63
660.94
608.65
561.41
387.88
Earnings per share (EPS)
0.41
0.45
0.44
0.35
0.33
0.19
0.31
Diluted Earnings per share
0.41
0.45
0.44
0.35
0.33
0.19
0.31
Operating Profit Margin (Excl OI)
45.24%
44.81%
44.31%
39.56%
44.21%
27.54%
37.71%
Gross Profit Margin
53.73%
57.1%
59.03%
51.85%
53.21%
39.17%
50.51%
PAT Margin
35.55%
40.12%
39.44%
34.1%
33.24%
23.63%
31.51%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2025 is 19.48% vs 23.19% in Jun 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2025 is 27.70% vs 7.94% in Jun 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2025 is 18.81% vs 15.37% in Jun 2024

stock-summary

Interest

No Interest in the last few periods

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024

Compare Quarterly Results Of Catalyst Pharmaceuticals, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
146.56
12.46
134.10
1,076.24%
Other Operating Income
0.00
0.00
0.00
Total Operating income
146.56
12.46
134.10
1,076.24%
Raw Material Cost
29.96
2.96
27.00
912.16%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
45.95
45.87
0.08
0.17%
Other Expenses
0.44
9.07
-8.63
-95.15%
Total Expenditure (Excl Depreciation)
80.27
139.51
-59.24
-42.46%
Operating Profit (PBDIT) excl Other Income
66.30
-127.06
193.36
152.18%
Other Income
5.95
15.04
-9.09
-60.44%
Operating Profit (PBDIT)
81.71
-110.76
192.47
173.77%
Interest
0.00
0.00
0.00
Exceptional Items
-2.95
0.00
-2.95
Gross Profit (PBDT)
116.61
9.49
107.12
1,128.77%
Depreciation
9.46
1.26
8.20
650.79%
Profit Before Tax
69.29
-112.02
181.31
161.86%
Tax
17.18
0.00
17.18
Provisions and contingencies
0
0
0.00
Profit After Tax
52.11
-112.02
164.13
146.52%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
52.11
-112.02
164.13
146.52%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
52.11
-112.02
164.13
146.52%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
856.03
1,369.56
-513.53
-37.50%
Earnings per share (EPS)
0.41
-1.93
2.34
121.24%
Diluted Earnings per share
0.41
-1.93
2.34
121.24%
Operating Profit Margin (Excl OI)
45.24%
-1,020.12%
0.00
1,065.36%
Gross Profit Margin
53.73%
-889.29%
0.00
943.02%
PAT Margin
35.55%
-899.40%
0.00
934.95%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 14.66 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 3.68% vs -0.28% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 19.48% vs 23.19% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 5.21 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -8.11% vs 1.43% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 27.70% vs 7.94% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 7.58 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 4.12% vs 0.55% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 18.81% vs 15.37% in Jun 2024

Quarterly - Interest
Markets Mojo
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 45.24%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024